MIRA Pharmaceuticals, Inc.(NASDAQ:MIRA) 
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitiv...
Website: https://www.mirapharmaceuticals.com/
Founded: 2020
IPO Price: $7 (Aug 03, 2023)
CEO: Erez Aminov
Sector: ...
Industry: Pharmaceuticals
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.94
H 0.94
L 0.81
C 0.83
V 135,732
10EMA 0.83
20EMA 0.83
60EMA 0.83
120EMA 0.83
250EMA 0.83